Taiwan FDA registration 684efc1557ddf40b1cfb39a22ea518a6

Roche silver staining in situ hybrid dinitrophenol detection agent (unsterilized)

TW: 羅氏銀染原位雜交二硝基酚偵測試劑(未滅菌)

Taiwan·Risk Class 1·ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.·Registered Sep 27, 2010 – Sep 27, 2025Expired

Registration details

Analysis ID: 684efc1557ddf40b1cfb39a22ea518a6
Customs Code: DHA04400925802

Company information

Manufacturer: ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.
Manufacturer Country: United States;;Germany
Authorized Representative: ROCHE DIAGNOSTICS LTD.

Product details

Intended Use: Limit the classification and grading management of medical equipment "immunopathological histochemical reagents and sets (B.1860) the first level identification range.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.1860 Immunopathological histochemistry reagents and kits
Import Information: import

Dates and status

Registration Date: Sep 27, 2010
Expiry Date: Sep 27, 2025

About this record

Access comprehensive regulatory information for Roche silver staining in situ hybrid dinitrophenol detection agent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 684efc1557ddf40b1cfb39a22ea518a6 and manufactured by ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.